Extraordinary pricing of orphan drugs : is it a socially responsible strategy for the US pharmaceutical industry?
Year of publication: |
2010
|
---|---|
Authors: | Hemphill, Thomas A. |
Published in: |
Journal of business ethics : JOBE. - Dordrecht : Springer, ISSN 0167-4544, ZDB-ID 868017-6. - Vol. 94.2010, 2, p. 225-242
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Preismanagement | Pricing strategy | Arzneimittel | Pharmaceuticals | Nischenstrategie | Niche marketing strategy | Corporate Social Responsibility | Corporate social responsibility | USA | United States |
-
Case description : the pharmaceutical industry and the AIDS crisis
Verweij, Marcel, (2011)
-
Bargaining and international reference pricing in the pharmaceutical industry
Dubois, Pierre, (2022)
-
Corporate ethics in the pharmaceutical industry : the Lipobay/Baycol case of Bayer
Berg, Nicola, (2006)
- More ...
-
Hemphill, Thomas A., (2020)
-
Generic drug competition: The pharmaceutical industry “gaming” controversy
Hemphill, Thomas A., (2019)
-
White III, George O., (2020)
- More ...